Top Abstract Purchase Related
Home
>
Node
>
Subnode

Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography

Saku, K.; Takeda, Y.; Jimi, S.; Okabe, M.; Shirai, K.; Nii, T.; Naito, S.; Arakawa, K.

Journal of Cardiology 31(4): 239-245

1998

ISSN/ISBN: 0914-5087
PMID: 9594373
Document Number: 489432
A 62-year-old man with old myocardial infarction and familial hypercholesterolemia was treated by both probucol and low-density lipoprotein (LDL) apheresis. Coronary angiography was performed before and after 3.5 years of LDL apheresis treatment, and no new lesion or progression of coronary atherosclerosis was observed. LDL apheresis drastically reduced the serum total cholesterol. However, it is still unclear whether LDL apheresis effectively prevented the recurrence of cardiac events and the progression of coronary atherosclerosis in this patient.

Document emailed within 1 workday
Secure & encrypted payments

Saku, K.; Takeda, Y.; Shirai, K.; Nii, T.; Ohta, T.; Arakawa, K. 1997: Long-term follow-up by coronary angiography in a patient with heterozygous familial hypercholesterolemia: a case report Journal of Cardiology 30(3): 137-142
Bokchubaev, E.T.; Kukharchuk, V.V.; Nasonov, E.L.; Konovalov, G.A.; Masenko, V.P. 1992: Effect of low-density lipoprotein apheresis on the complement system in patients with hereditary hypercholesterolemia Klinicheskaia Meditsina 70(9-10): 45-48
Ros Rahola, E. 1993: The apheresis of low-density lipoproteins in homozygous familial hypercholesterolemia Medicina Clinica 100(3): 117-118
Hailer, S.; Pogarell, O.; Keller, C.; Wolfram, G. 1996: Effect of fluvastatin or bezafibrate on the distribution of high density lipoprotein subpopulations in patients with familial hypercholesterolemia Arzneimittel-Forschung 46(9): 879-883
Bokchubaev, E.T.; Konovalov, G.A.; Nasonov, E.L.; Kukharchuk, V.V. 1991: The dynamics of the concentrations of immunoglobulins and circulating immune complexes during low-density lipoprotein apheresis in patients with hereditary hypercholesterolemia Terapevticheskii Arkhiv 63(9): 62-64
Konovalov, G.A. 1991: Extracorporeal methods for low-density lipoprotein apheresis in treating patients with severe forms of hereditary hypercholesterolemia. a review Terapevticheskii Arkhiv 63(10): 111-119
Iarovaia, E.B.; Rostapshova, T.V.; Susekov, A.V.; Kukharchuk, V.V. 1993: The choice of the optimal regimen for apheresis of the low-density lipoproteins in patients with familial hypercholesterolemia by using mathematical modelling Kardiologiia 33(10): 50
Tilly-Kiesi, M.; Tikkanen, M.J. 1992: Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 120(1): 103-110
Marson, P.; Boschetto, R.; De Silvestro, G.; Martini, S.; Gabelli, C.; Buoro, S.; Giordano, R.; Palù, G. 1999: Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia International Journal of Artificial Organs 22(9): 640-644
Ferrières, J.; Lambert, J.; Lussier-Cacan, S.; Davignon, J. 1995: Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation Circulation 92(3): 290-295
Donner, M.G.; Richter, W.O.; Schwandt, P. 1997: Long term effect of LDL apheresis on coronary heart disease European Journal of Medical Research 2(6): 270-274
Mandel'shtam, M.I.; Lipovetskiĭ, B.M.; Shvartsman, A.L.; Gaĭtskhoki, V.S. 1995: A multiexon deletion in the human low density lipoprotein receptor gene as a reason for familial hypercholesterolemia Genetika 31(2): 259-263
Meshkov, A.N.; Stambol'skiĭ, D.V.; Krapivner, S.R.; Bochkov, V.N.; Kukharchuk, V.V.; Malyshev, P.P. 2004: Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia Kardiologiia 44(9): 58-61
Semenkovich, C.F.; Ostlund, R.E.; Yang, J.; Reaban, M.E. 1985: Demonstration of functional low-density lipoprotein receptors by protein blotting in fibroblasts from a subject with homozygous receptor-negative familial hypercholesterolemia Journal of Laboratory and Clinical Medicine 106(1): 47-52
Turk, Z.; Mrzljak, V.; Turk, N.; Metelko, Z. 1999: Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis Diabetes Nutrition and Metabolism 12(6): 413-417
Bláha, V.ír.; Bláha, M.; Lánská, M.; Havel, E.; Vyroubal, P.; Zadák, Z.ěk.; Žák, P.; Sobotka, L.š 2014: LDL-apheresis in the treatment familial hypercholesterolemia Vnitrni Lekarstvi 60(11): 970-976
Leclercq, V.; Harvengt, C. 1989: Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial International Journal of Clinical Pharmacology Therapy and Toxicology 27(2): 76-81
Bo, M.; Nicolello, M.T.; Fiandra, U.; Mercadante, G.; Piliego, T.; Fabris, F. 2001: Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin Nutrition Metabolism and Cardiovascular Diseases: Nmcd 11(1): 17-24
Balestrieri, G.P.; Maffi, V.; Sleiman, I.; Spandrio, S.; Di Stefano, O.; Salvi, A.; Scalvini, T. 1996: Fish oil supplementation in patients with heterozygous familial hypercholesterolemia Recenti Progressi in Medicina 87(3): 102-105
Napoli, C.; Postiglione, A.; Scarpato, N.; Corso, G.; Ambrosio, G.; Condorelli, M.; Mancini, M.; Chiariello, M. 1996: LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment Cardiologia 41(5): 435-439